We surmise that additional hits of genetic abnormalities (which are more likely to occur in older people) interact with the age-dependent perturbation of the hematopoietic niche to result in clinical NPM1-mutated AML among older patients. The gene discussed is NPM1; the disease is acute myeloid leukemia.